Skip to content
✕

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Heart icon (animated) heart icon (static)
Our Stories
Our Company
Follow Us
Explore more Johnson & Johnson sites:
Australia
A graphic of the flag of Australia alt
Argentina
A graphic of the flag of Argentina alt
Brazil
A graphic of the flag of Brazil alt
Canada
A graphic of the national flag of Canada alt
Chile
A graphic of the flag of Chile alt
China
A graphic of the national flag of the People's Republic of China alt
Colombia
A graphic of the national flag of Colombia alt
Costa Rica
A graphic of the national flag of Costa Rica alt
Czech Republic
Ecuador
A graphic of the national flag of Ecuador alt
Germany
A graphic of the flag of Germany alt
India
A graphic of the national flag of India alt
Japan
A graphic of the national flag of Japan alt
Mexico
A graphic of the flag of Mexico alt
New Zealand / Pacific
A graphic of the flag of New Zealand alt
Paraguay
A graphic of the flag of Paraguay alt
Peru
A graphic of the flag of Peru alt
Philippines
A graphic of the national flag of the Philippines alt
Russia
A graphic of the flag of Russia alt
Switzerland
A graphic of the flag of Switzerland alt
German
English
French
United Kingdom
A graphic of the national flag of the U.K. alt
United States
A graphic of the flag of the United States of America alt
Uruguay
A graphic of the national flag of Uruguay alt
Venezuela
A graphic of the flag of Venezuela alt
Members of a Johnson & Johnson HIV prevention program in South Africa alt
Read the Story
5 Ways Johnson & Johnson Is Working to Improve the Well-Being of the World by 2025
5 Ways Johnson & Johnson Is Working to Improve the Well-Being of the World by 2025
Johnson & Johnson's 2020 Health for Humanity Report details the progress it's made in the past five years in driving sustainable social, environmental and economic change around the globe. Now the company's looking ahead to the next five.
Read the Story
How Johnson & Johnson Has Pioneered in the Battle Against HIV/AIDS
How Johnson & Johnson Has Pioneered in the Battle Against HIV/AIDS
On the 40th anniversary of what would become the first AIDS diagnosis, we look at the groundbreaking strides the company has made—and continues to make—toward a world without the disease.
People given cataract surgeries by Himalayan Cataract Project, an organization devoted to eliminating preventable and curable blindness alt
Read the Story
9 Ways Johnson & Johnson Is Sharing Its Vision for Good With the World
9 Ways Johnson & Johnson Is Sharing Its Vision for Good With the World
As Johnson & Johnson Vision publishes its annual impact report, we share stats about how the company is helping expand eye care across the globe through advocacy, education and sustainable innovation.
Lung cancer researcher in a laboratory alt
Read the Story
The Quest to Help Patients with a Deadly Type of Lung Cancer
The Quest to Help Patients with a Deadly Type of Lung Cancer
Despite obstacles and setbacks, these researchers vowed to never give up working to develop a new treatment for non-small cell lung cancer. As the drug receives FDA approval, they share their journey.
Read the Story
3 Innovative Ways Johnson & Johnson Proudly Supports the LGBTQIA+ Community
3 Innovative Ways Johnson & Johnson Proudly Supports the LGBTQIA+ Community
From inclusive benefits to partnerships with nonprofits, the company aims to be a strong ally during Pride Month—and beyond.
Pregnant woman looking at sonogram alt
Read the Story
What to Know About HDFN—a Serious Blood Disorder in Babies—Including a Possible New Treatment
What to Know About HDFN—a Serious Blood Disorder in Babies—Including a Possible New Treatment
Severe cases of hemolytic disease of the fetus and newborn can be deadly in infants. That's why Johnson & Johnson is passionate about investigating a promising option for treating the disorder.
Read the Story
6 Latest Facts About Johnson & Johnson's Ebola Vaccine
6 Latest Facts About Johnson & Johnson's Ebola Vaccine
In response to a new Ebola outbreak in Guinea, Johnson & Johnson is providing up to 200,000 doses of its Ebola vaccine regimen to the country for a World Health Organization supported clinical trial. Learn more about the initiative and other top facts about the vaccine regimen for the deadly virus.
Read the Story
8 Things We Learned From the New Neutrogena Documentary In the Sun
8 Things We Learned From the New Neutrogena Documentary In the Sun
Through powerful personal stories, the first film from the skin health brand shares important info about preventing melanoma. Here's what it wants viewers to know about staying protected.

Johnson & Johnson Proudly Supports the LGBTQIA+ Community

In honor of Pride Month, read about the company's commitment to allyship and ensuring that its employees feel safe and accepted through inclusive policies, business practices and public advocacy.
Quote icon (top)

I feel I have a responsibility as a woman of color who works in skin health to contribute to helping resolve racial disparities that exist in my industry in a meaningful way. I would like to be known as someone who elevated the voices that are less heard and for being someone who didn’t take good as good enough.

— Amrika Ganness , Director, Strategy and Management Support, Consumer Health North America
Read More in Our Story
Quote icon (bottom)
Johnson & Johnson Named to the TIME100 Most Influential Companies List
Johnson & Johnson Named to the TIME100 Most Influential Companies List
Johnson & Johnson Single-Shot COVID-19 Vaccinations to Resume in the U.S. Following CDC and FDA Decision
Johnson & Johnson Single-Shot COVID-19 Vaccinations to Resume in the U.S. Following CDC and FDA Decision
What You Need to Know About Johnson & Johnson's 2021 First-Quarter Earnings
What You Need to Know About Johnson & Johnson's 2021 First-Quarter Earnings
2 Pandemics, 1 Goal: Meet 4 Innovators with High-Tech Ideas for Fighting Tuberculosis in the Time of COVID-19
2 Pandemics, 1 Goal: Meet 4 Innovators with High-Tech Ideas for Fighting Tuberculosis in the Time of COVID-19
8 Things to Know About Johnson & Johnson's Janssen COVID-19 Vaccine
8 Things to Know About Johnson & Johnson's Janssen COVID-19 Vaccine
Image of young child with skeleton overlay alt Image of young child with skeleton overlay
4 Things Scientists Now Know About Autoimmune Diseases in Kids
4 Things Scientists Now Know About Autoimmune Diseases in Kids
One Year Later: The Head of Johnson & Johnson China Looks Back on What We've Learned From the Pandemic—and How It Can Help Shape the Future
The Head of Johnson & Johnson China Looks Back on What We've Learned From the Pandemic—and How It Can Help Shape the Future
A Look Back on Our Work in 2020
A Look Back on Our Work in 2020
4 Things We Now Know About the Rare Disease AL Amyloidosis
4 Things We Now Know About the Rare Disease AL Amyloidosis
3 Eye-Opening Statistics About Racial Inequities in Heart Health Among Black Americans
3 Eye-Opening Statistics About Racial Inequities in Heart Health Among Black Americans

Recent Johnson & Johnson Initiatives in the Spotlight

Learn more about the company’s latest groundbreaking programs, game-changing innovations and global partnerships—all aimed at helping change the trajectory of health for humanity.
This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
Close cookie banner icon
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue